GlassScriptPhysician profile
Jonathan A Koretoff
NPI 1346668779
$1,223.00
in general payments reported to CMS, 2019-2025
20 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.63 · 2020: $152 · 2021: $90.13 · 2022: $158 · 2023: $119 · 2024: $419 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $167.64 | 2021-2023 | Octrode |
| Hologic Sales and Service, LLC | $115.28 | 2024-2025 | Aptima |
| Pacira Therapeutics, INC. | $101.78 | 2019-2021 | |
| Pfizer INC. | $88.64 | 2023-2025 | |
| Radius Health, INC. | $87.75 | 2024 | |
| Exact Sciences Corporation | $76.04 | 2024-2025 | Cologuard Collection Kit |
| Depuy Synthes Sales INC. | $69.28 | 2019-2021 | |
| Abbvie INC. | $65.94 | 2023-2025 | |
| Team_makena_llc | $62.57 | 2019-2020 | |
| Amgen INC. | $57.98 | 2022-2025 | Prolia, Evenity |
| Djo, LLC | $48.94 | 2020 | |
| Edwards Lifesciences Corporation | $48.80 | 2024 | Sapien 3 Ultra Resilia |
| Glaxosmithkline, LLC. | $47.88 | 2024-2025 | Arexvy, Shingrix |
| Idorsia Pharmaceuticals US INC | $41.82 | 2023 | Quviviq |
| Philips North America LLC | $35.44 | 2024 | (Ck7) Extended Holter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $32.30 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Boston Scientific Corporation | $20.12 | 2020 | |
| Phadia US INC. | $19.88 | 2024 | Immunocap |
| Tempus Ai, INC | $18.52 | 2024 | |
| Bioventus LLC | $16.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Koretoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.